Live feed17:15:00·44dPRReleasevia QuantisnowNuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026ByQuantisnow·Wall Street's wire, on your screen.NUVL· Nuvalent Inc.Health Care
